Study Protocol of a Phase 2, Randomised, Placebo-Controlled, Double-Blind, Adaptive, Parallel Group Clinical Study to Evaluate the Efficacy and Safety of Recombinant Alpha-1-microglobulin in Subjects at High Risk for Acute Kidney Injury Following Open-Chest Cardiac Surgery (AKITA Trial).
BMJ OPEN(2023)
关键词
Cardiac surgery,Acute renal failure,Adult intensive & critical care
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要